The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.

<h4>Background</h4>Non-invasive prenatal testing (NIPT) is a widely adopted maternal blood test that analyses foetal originating DNA to screen for foetal chromosomal conditions, including Down's syndrome (DS). The introduction of this test, which may have implications for important...

Full description

Saved in:
Bibliographic Details
Main Authors: Elinor Sebire, Chithramali Hasanthika Rodrigo, Sohinee Bhattacharya, Mairead Black, Rachael Wood, Rute Vieira
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298643&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595724308578304
author Elinor Sebire
Chithramali Hasanthika Rodrigo
Sohinee Bhattacharya
Mairead Black
Rachael Wood
Rute Vieira
author_facet Elinor Sebire
Chithramali Hasanthika Rodrigo
Sohinee Bhattacharya
Mairead Black
Rachael Wood
Rute Vieira
author_sort Elinor Sebire
collection DOAJ
description <h4>Background</h4>Non-invasive prenatal testing (NIPT) is a widely adopted maternal blood test that analyses foetal originating DNA to screen for foetal chromosomal conditions, including Down's syndrome (DS). The introduction of this test, which may have implications for important decisions made during pregnancy, requires continual monitoring and evaluation. This systematic review aims to assess the extent of NIPT introduction into national screening programmes for DS worldwide, its uptake, and impact on pregnancy outcomes.<h4>Methods and findings</h4>The study protocol was published in PROSPERO (CRD42022306167). We systematically searched MEDLINE, CINAHL, Scopus, and Embase for population-based studies, government guidelines, and Public Health documents from 2010 onwards. Results summarised the national policies for NIPT implementation into screening programmes geographically, along with population uptake. Meta-analyses estimated the pooled proportions of women choosing invasive prenatal diagnosis (IPD) following a high chance biochemical screening result, before and after NIPT was introduced. Additionally, we meta-analysed outcomes (termination of pregnancy and live births) amongst high chance pregnancies identified by NIPT. Results demonstrated NIPT implementation in at least 27 countries. Uptake of second line NIPT varied, from 20.4% to 93.2% (n = 6). Following NIPT implementation, the proportion of women choosing IPD after high chance biochemical screening decreased from 75% (95% CI 53%, 88%, n = 5) to 43% (95%CI 31%, 56%, n = 5), an absolute risk reduction of 38%. A pooled estimate of 69% (95% CI 52%, 82%, n = 7) of high chance pregnancies after NIPT resulted in termination, whilst 8% (95% CI 3%, 21%, n = 7) had live births of babies with DS.<h4>Conclusions</h4>NIPT has rapidly gained global acceptance, but population uptake is influenced by healthcare structures, historical screening practices, and cultural factors. Our findings indicate a reduction in IPD tests following NIPT implementation, but limited pre-NIPT data hinder comprehensive impact assessment. Transparent, comparable data reporting is vital for monitoring NIPT's potential consequences.
format Article
id doaj-art-f4e24cd16da940c79ecdaf505607e04f
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-f4e24cd16da940c79ecdaf505607e04f2025-01-18T05:31:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01195e029864310.1371/journal.pone.0298643The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.Elinor SebireChithramali Hasanthika RodrigoSohinee BhattacharyaMairead BlackRachael WoodRute Vieira<h4>Background</h4>Non-invasive prenatal testing (NIPT) is a widely adopted maternal blood test that analyses foetal originating DNA to screen for foetal chromosomal conditions, including Down's syndrome (DS). The introduction of this test, which may have implications for important decisions made during pregnancy, requires continual monitoring and evaluation. This systematic review aims to assess the extent of NIPT introduction into national screening programmes for DS worldwide, its uptake, and impact on pregnancy outcomes.<h4>Methods and findings</h4>The study protocol was published in PROSPERO (CRD42022306167). We systematically searched MEDLINE, CINAHL, Scopus, and Embase for population-based studies, government guidelines, and Public Health documents from 2010 onwards. Results summarised the national policies for NIPT implementation into screening programmes geographically, along with population uptake. Meta-analyses estimated the pooled proportions of women choosing invasive prenatal diagnosis (IPD) following a high chance biochemical screening result, before and after NIPT was introduced. Additionally, we meta-analysed outcomes (termination of pregnancy and live births) amongst high chance pregnancies identified by NIPT. Results demonstrated NIPT implementation in at least 27 countries. Uptake of second line NIPT varied, from 20.4% to 93.2% (n = 6). Following NIPT implementation, the proportion of women choosing IPD after high chance biochemical screening decreased from 75% (95% CI 53%, 88%, n = 5) to 43% (95%CI 31%, 56%, n = 5), an absolute risk reduction of 38%. A pooled estimate of 69% (95% CI 52%, 82%, n = 7) of high chance pregnancies after NIPT resulted in termination, whilst 8% (95% CI 3%, 21%, n = 7) had live births of babies with DS.<h4>Conclusions</h4>NIPT has rapidly gained global acceptance, but population uptake is influenced by healthcare structures, historical screening practices, and cultural factors. Our findings indicate a reduction in IPD tests following NIPT implementation, but limited pre-NIPT data hinder comprehensive impact assessment. Transparent, comparable data reporting is vital for monitoring NIPT's potential consequences.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298643&type=printable
spellingShingle Elinor Sebire
Chithramali Hasanthika Rodrigo
Sohinee Bhattacharya
Mairead Black
Rachael Wood
Rute Vieira
The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
PLoS ONE
title The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
title_full The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
title_fullStr The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
title_full_unstemmed The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
title_short The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
title_sort implementation and impact of non invasive prenatal testing nipt for down s syndrome into antenatal screening programmes a systematic review and meta analysis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298643&type=printable
work_keys_str_mv AT elinorsebire theimplementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT chithramalihasanthikarodrigo theimplementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT sohineebhattacharya theimplementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT maireadblack theimplementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT rachaelwood theimplementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT rutevieira theimplementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT elinorsebire implementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT chithramalihasanthikarodrigo implementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT sohineebhattacharya implementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT maireadblack implementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT rachaelwood implementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis
AT rutevieira implementationandimpactofnoninvasiveprenataltestingniptfordownssyndromeintoantenatalscreeningprogrammesasystematicreviewandmetaanalysis